Pancreatobiliary Diversion in the Mouse
- PMID: 33260177
- DOI: 10.1159/000508270
Pancreatobiliary Diversion in the Mouse
Abstract
The gut hormone cholecystokinin (CCK) is primarily secreted from I-cells in the duodenum and proximal jejunum. CCK secretion is stimulated by food digests and inhibited by proteases from pancreatic juice. CCK regulates digestion and appetite, stimulates pancreatic growth, and participates in pancreatic carcinogenesis. The molecular mechanisms of CCK-induced effects are not fully understood. When the mechanisms are studied in animals, the surgical model of pancreatobiliary diversion (PBD) is frequently used. After animals have had PBD, their CCK secretion is no longer inhibited by pancreas-derived proteases, so circulating CCK is increased. PBD is established in rats and hamsters, but not in mice. In this study, we modified PBD procedures and established the model in the mouse. In an experiment, we performed PBD and sham operation (SO) in two groups of mice (20 mice per group). Twenty days after operation, 75% of the PBD mice and all SO mice survived. When plasma CCK was determined by radioimmunoassay, the PBD group had higher levels than the SO group (p < 0.001). To assess pancreatic growth, we determined pancreatic weight and pancreatic contents of protein and DNA. We also stained pancreatic sections by immunohistochemistry to show the proliferating cells that either expressed the proliferating cell nuclear antigen or were labeled with 5-bromo-2'-deoxyuridine. As a result, the pancreases of the PBD mice were heavier (p < 0.001) and had more protein (p < 0.001), DNA (p < 0.01), and proliferating cells (p < 0.01) than those of the SO counterparts. Thus, pancreatic growth was increased as a result of PBD-induced hypercholecystokininemia. The plasma and pancreatic data demonstrated that the PBD model was a success. This model may be used in CCK-related research. For instance, pancreatic cancer is frequently studied in transgenic mice. PBD may be combined with the cancer model to study the role of CCK in the molecular biology of pancreatic cancer.
Keywords: Cholecystokinin; Mouse; Pancreas; Pancreatobiliary diversion.
© 2020 S. Karger AG, Basel.
Similar articles
-
Inhibitory effect of a cholecystokinin antagonist on pancreatic carcinogenesis after pancreatobiliary diversion.Br J Cancer. 1993 Apr;67(4):663-7. doi: 10.1038/bjc.1993.123. Br J Cancer. 1993. PMID: 8471422 Free PMC article.
-
Effects of intraluminal trypsin and bile on the exocrine and endocrine pancreas after pancreaticobiliary diversion and biliodigestive shunt.Pancreas. 2000 Mar;20(2):170-6. doi: 10.1097/00006676-200003000-00010. Pancreas. 2000. PMID: 10707933
-
Pancreatic growth after pancreatico-biliary diversion does not increase the capacity to secrete amylase.Eur Surg Res. 1999;31(2):187-95. doi: 10.1159/000008638. Eur Surg Res. 1999. PMID: 10213858
-
Cholecystokinin and pancreatic cancer: the chicken or the egg?Am J Physiol Gastrointest Liver Physiol. 2014 Jan;306(2):G91-G101. doi: 10.1152/ajpgi.00301.2013. Epub 2013 Oct 31. Am J Physiol Gastrointest Liver Physiol. 2014. PMID: 24177032 Free PMC article. Review.
-
Regulation of cholecystokinin secretion by intraluminal releasing factors.Am J Physiol. 1995 Sep;269(3 Pt 1):G319-27. doi: 10.1152/ajpgi.1995.269.3.G319. Am J Physiol. 1995. PMID: 7573441 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials